Global Stereotactic Body Radiation Therapy Market Size By Type (Linear Accelerator (LINAC) Machines, Proton Beam (charged particle)), By Application (Carcinogenesis, Non-cancerous Abnormality), By Reg...

The Global Stereotactic Body Radiation Therapy (SBRT) Market was valued at USD 5.1 billion in 2023 and is projected to reach USD 10.4 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2023–2031). SBRT has become a game-changer in the field of cancer treatment, delivering highly precise and potent doses of radiation to tumors while minimizing damage to surrounding healthy tissues. Its adoption is being driven by the increasing prevalence of cancer, advancements in radiation technology, and the growing preference for non-invasive treatment options.

As healthcare providers and oncology centers continue to seek effective alternatives to conventional therapies, the demand for SBRT is surging. The therapy’s shorter treatment durations, improved patient outcomes, and reduced hospitalization costs are positioning SBRT as a preferred solution in modern cancer care.

Drivers:

1. Rising Cancer Incidence Globally:

The increasing global burden of cancer, especially lung, liver, and prostate cancers, is one of the primary drivers for the SBRT market. As the aging population grows, the need for advanced treatment methods like SBRT becomes more pronounced.

2. Advancements in Radiotherapy Technologies:

Technological innovations such as image-guided radiotherapy (IGRT), real-time tumor tracking, and adaptive radiotherapy are enhancing the precision and safety of SBRT, making it more effective and widely adoptable.

3. Growing Demand for Non-Invasive Treatments:

Patients are increasingly seeking treatment options that are less invasive and require fewer hospital visits. SBRT, with its outpatient treatment capability and minimal recovery time, aligns perfectly with these preferences.

Restraints:

1. High Cost of Equipment and Installation:

SBRT systems involve significant capital expenditure for installation and maintenance. This can be a barrier for smaller hospitals, particularly in developing countries.

2. Limited Access in Low- and Middle-Income Countries (LMICs):

Despite its advantages, access to SBRT remains limited in LMICs due to inadequate infrastructure and limited radiotherapy workforce.

Opportunity:

1. Expansion of Cancer Care in Emerging Markets:

With governments in emerging economies focusing on strengthening oncology services, there is a notable opportunity for SBRT providers to expand into new geographic territories.

2. Integration with AI and Machine Learning:

The use of AI-driven planning systems in SBRT can further enhance treatment accuracy and efficiency, opening up new avenues for innovation and market growth.

Market by System Type Insights:

The Linear Accelerator (LINAC)-based SBRT systems dominated the market in 2023, driven by their widespread adoption and integration with imaging systems. These systems offer excellent precision and flexibility, making them suitable for a broad range of tumor types. However, CyberKnife systems are gaining traction due to their robotic precision and real-time tracking capabilities, particularly in hard-to-reach tumors.

Market by End-use Insights:

Hospitals emerged as the largest end-user segment in 2023, accounting for over 50% of the global revenue. Their ability to invest in high-cost SBRT systems and cater to a large patient base makes them key players in the market. Cancer specialty clinics are expected to witness the fastest growth, owing to the increasing trend of outpatient treatment and the demand for focused oncology care.

Market by Regional Insights:

North America led the global SBRT market in 2023, supported by a well-established healthcare infrastructure, high cancer incidence, and rapid adoption of advanced technologies. Asia-Pacific is projected to experience the highest CAGR through 2031, driven by growing healthcare investments, rising awareness of radiation therapy, and the increasing burden of cancer in countries like China and India.

Competitive Scenario:

Leading companies in the SBRT market include Varian Medical Systems (a Siemens Healthineers company), Elekta AB, Accuray Incorporated, ViewRay Inc., Brainlab AG, and RefleXion Medical. These firms are actively investing in technological advancements, clinical trials, and geographic expansion to enhance their competitive position.

Recent Developments:

In 2023, Varian launched its new AI-powered radiotherapy planning platform, enhancing treatment customization and efficiency.

In 2024, Accuray received regulatory clearance for an upgraded CyberKnife system with advanced motion synchronization features.

In 2025, Elekta announced a strategic partnership with a leading oncology network to deploy SBRT systems across Southeast Asia.

Scope of Work – Global Stereotactic Body Radiation Therapy Market

Report Metric Details

Market Size (2023) USD 5.1 billion

Projected Market Size (2031) USD 10.4 billion

CAGR (2023–2031) 9.0%

Market Segments System Type (LINAC, CyberKnife), End-use, Region

Growth Drivers Rising cancer incidence, tech advancements, non-invasive treatment demand

Opportunities Emerging markets expansion, AI-driven SBRT tools

Key Market Developments:

2023: Varian launches AI-enhanced treatment planning software for SBRT.

2024: Accuray receives FDA approval for a next-gen CyberKnife system.

2025: Elekta partners with regional oncology centers in Asia-Pacific to expand SBRT access.

FAQs:

1) What is the current market size of the Global Stereotactic Body Radiation Therapy Market?

The market was valued at USD 5.1 billion in 2023.

2) What is the major growth driver of the Global Stereotactic Body Radiation Therapy Market?

The rising incidence of cancer and growing demand for non-invasive treatment options are key drivers.

3) Which is the largest region during the forecast period in the Global Stereotactic Body Radiation Therapy Market?

North America holds the largest market share due to its advanced healthcare infrastructure and high adoption of SBRT.

4) Which segment accounted for the largest market share in Global Stereotactic Body Radiation Therapy Market?

The Linear Accelerator (LINAC)-based systems segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Stereotactic Body Radiation Therapy Market?

Key players include Varian Medical Systems, Elekta AB, Accuray Incorporated, ViewRay Inc., Brainlab AG, and RefleXion Medical.